deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 2-arm NCT00282438

Hematopoietic Stem Cell Support in Patients With Refractory Sarcoidosis

Hematopoietic Stem Cell Transplant in Patients With Refractory Sarcoidosis: A Phase I/II Trial

Sponsor: Northwestern University

Conditions Sarcoidosis
Interventions Allogeneic stem cell transplantation Autologous hematopoietic stem cell transplantation
Updated 9 times since 2017 Last updated: Aug 3, 2018 Started: Dec 31, 2003 Primary completion: Aug 31, 2015 Completion: Aug 31, 2015
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

No plan to continue enrollment

Other terminated trials from Northwestern University

See all terminations from Northwestern University

Other Sarcoidosis trials with similar outcome

Browse all Sarcoidosis trials

This PHASE1/PHASE2 trial investigates Sarcoidosis and is currently terminated or withdrawn. Northwestern University leads this study, which shows 9 recorded versions since 2003 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotTerminated~Feb 2017 – ~May 2017 · 3 months · monthly snapshotTerminated~May 2017 – ~Jun 2018 · 13 months · monthly snapshotTerminated~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshotTerminated~Sep 2018 – ~Jan 2021 · 28 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – present · 24 months · monthly snapshotTerminated

Change History

9 versions recorded

  1. Sep 2024 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  4. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE1_PHASE2

  5. Sep 2018 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

▶ Show 4 earlier versions

  1. Jun 2018 — Sep 2018 [monthly]

    Terminated PHASE1_PHASE2

  2. May 2017 — Jun 2018 [monthly]

    Terminated PHASE1_PHASE2

  3. Feb 2017 — May 2017 [monthly]

    Terminated PHASE1_PHASE2

  4. Jan 2017 — Feb 2017 [monthly]

    Terminated PHASE1_PHASE2

    First recorded

Dec 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Northwestern University
Data source: Northwestern University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations